The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer
Open accessAbstract
CONTEXT: There has been rapid adoption of newer radiation treatments such as intensity-modulated radiation therapy (IMRT) and proton therapy despite greater cost and limited demonstrated benefit compared with previous technologies. OBJECTIVE: To determine the comparative morbidity and disease control of IMRT, proton therapy, and conformal radiation therapy for primary prostate cancer treatment. DESIGN, SETTING, AND PATIENTS: Population-based study using Surveillance, Epidemiology, and End Results-Medicare-linked data from 2000 through 2009 for patients with nonmetastatic prostate cancer. MAIN OUTCOME MEASURES: Rates of gastrointestinal and urinary morbidity, erectile dysfunction, hip fractures, and additional cancer therapy. RESULTS: Use of IMRT vs conformal radiation therapy increased from 0.15% in 2000 to 95.9% in 2008. In propensity score-adjusted analyses (N = 12,976), men who received IMRT vs conformal radiation therapy were less likely to receive a diagnosis of gastrointestinal morbidities (absolute risk, 13.4 vs 14.7 per 100 person-years; relative risk [RR], 0.91; 95% CI, 0.86-0.96) and hip fractures (absolute risk, 0.8 vs 1.0 per 100 person-years; RR, 0.78; 95% CI, 0.65-0.93) but more likely to receive a diagnosis of erectile dysfunction (absolute risk, 5.9 vs 5.3 per 100 person-years; RR, 1.12; 95% CI, 1.03-1.20). Intensity-modulated radiation therapy patients were less likely to receive additional cancer therapy (absolute risk, 2.5 vs 3.1 per 100 person-years; RR, 0.81; 95% CI, 0.73-0.89). In a propensity score-matched comparison between IMRT and proton therapy (n = 1368), IMRT patients had a lower rate of gastrointestinal morbidity (absolute risk, 12.2 vs 17.8 per 100 person-years; RR, 0.66; 95% CI, 0.55-0.79). There were no significant differences in rates of other morbidities or additional therapies between IMRT and proton therapy. CONCLUSIONS: Among patients with nonmetastatic prostate cancer, the use of IMRT compared with conformal radiation therapy was associated with less gastrointestinal morbidity and fewer hip fractures but more erectile dysfunction; IMRT compared with proton therapy was associated with less gastrointestinal morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Risk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
Pollack, A., Zagars, G. K., Starkschall, G., Antolak, J. A., Lee, J. J., Huang, E., von Eschenbach, A. C., Kuban, D. A., & Rosen, I. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02829-8 · Cited by 1,333
Zietman, A. L., DeSilvio, M. L., Slater, J. D., Rossi, C. J., Miller, D. W., Adams, J. A., & Shipley, W. U. (2005) · JAMA · doi:10.1001/jama.294.10.1233 · Cited by 1,224
Dearnaley, D. P., Sydes, M. R., Graham, J. D., Aird, E. G., Bottomley, D., Cowan, R. A., Huddart, R. A., Jose, C. C., Matthews, J. H., Millar, J., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70143-2 · Cited by 905
Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
Hu, J. C. (2009) · JAMA · doi:10.1001/jama.2009.1451 · Cited by 816
Zietman, A. L., Bae, K., Slater, J. D., Shipley, W. U., Efstathiou, J. A., Coen, J. J., Bush, D. A., Lunt, M., Spiegel, D. Y., Skowronski, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8475 · Cited by 735
Zelefsky, M. J., Levin, E. J., Hunt, M., Yamada, Y., Shippy, A. M., Jackson, A., & Amols, H. I. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.044 · Cited by 735
Radiation Dose–Volume Effects in Radiation-Induced Rectal Injury
Michalski, J. M., Gay, H., Jackson, A., Tucker, S. L., & Deasy, J. O. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.078 · Cited by 718
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680 · cited 1×
“These findings are consistent with those of previous studies reporting physician-assessed morbidity and patient-reported outcomes.(43-45) Furthermore, prostate cancer risk group was not available and can affect radiation dose and extent of treatment, with consequent effects on morbidity.”
Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00209 · Cited by 597
Pollack, A., Zagars, G. K., Smith, L. G., Lee, J. J., von Eschenbach, A. C., Antolak, J. A., Starkschall, G., & Rosen, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3904 · Cited by 521
Klabunde, C. N., Legler, J. M., Warren, J. L., Baldwin, L.-M., & Schrag, D. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.03.011 · Cited by 514
Radiation Dose–Volume Effects of the Urinary Bladder
Viswanathan, A. N., Yorke, E. D., Marks, L. B., Eifel, P. J., & Shipley, W. U. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.090 · Cited by 404
Instrumental variable methods in comparative safety and effectiveness research
Brookhart, M. A., Rassen, J. A., & Schneeweiss, S. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1908 · Cited by 332
Cost Implications of the Rapid Adoption of Newer Technologies for Treating Prostate Cancer
Nguyen, P. L., Gu, X., Lipsitz, S. R., Choueiri, T. K., Choi, W. W., Lei, Y., Hoffman, K. E., & Hu, J. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1217 · Cited by 308
Dose–volume effects for normal tissues in external radiotherapy: Pelvis
Fiorino, C., Valdagni, R., Rancati, T., & Sanguineti, G. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.08.004 · Cited by 273
Nutting, C. M., Convery, D. J., Cosgrove, V. P., Rowbottom, C., Padhani, A. R., Webb, S., & Dearnaley, D. P. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00653-2 · Cited by 231
Trofimov, A., Nguyen, P. L., Coen, J. J., Doppke, K. P., Schneider, R. J., Adams, J. A., Bortfeld, T. R., Zietman, A. L., DeLaney, T. F., & Shipley, W. U. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.018 · Cited by 223
Brookhart, M. A., & Schneeweiss, S. (2007) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1072 · Cited by 222
Al-Mamgani, A., Heemsbergen, W. D., Peeters, S. T. H., & Lebesque, J. V. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.063 · Cited by 220
Chen, R. C., Clark, J. A., & Talcott, J. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6486 · Cited by 199
Follow-up Prostate Cancer Treatments After Radical Prostatectomy: a Population-Based Study
Lu-Yao, G. L., Potosky, A. L., Albertsen, P. C., Wasson, J. H., Barry, M. J., & Wennberg, J. E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.166 · Cited by 196
Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial
Pollack, A., Zagars, G. K., Starkschall, G., Antolak, J. A., Lee, J. J., Huang, E., von Eschenbach, A. C., Kuban, D. A., Rosen, I., & Ritter, M. A. (2003) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/s1078-1439(03)00092-9 · Cited by 192
Radiation Dose–Volume Effects and the Penile Bulb
Roach, M., Nam, J., Gagliardi, G., El Naqa, I., Deasy, J. O., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.094 · Cited by 166
Systematic Review: Charged-Particle Radiation Therapy for Cancer
Terasawa, T., Dvorak, T., Ip, S., Raman, G., Lau, J., & Trikalinos, T. A. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00145 · Cited by 108
Bekelman, J. E., Mitra, N., Efstathiou, J. A., Liao, K., Sunderland, R. J., Yeboa, D. N., & Armstrong, K. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.006 · Cited by 91
Lips, I. M., Dehnad, H., Kruger, A. B., van Moorselaar, R. J. A., van der Heide, U. A., Battermann, J. J., & van Vulpen, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.013 · Cited by 84
Choe, K. S., Jani, A. B., & Liauw, S. L. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.026 · Cited by 79
Three‐dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture
Elliott, S. P., Jarosek, S. L., Alanee, S. R., Konety, B. R., Dusenbery, K. E., & Virnig, B. A. (2011) · Cancer · doi:10.1002/cncr.25994 · Cited by 54
Late gastrointestinal toxicity after radiation for prostate cancer
Giordano, S. H., Lee, A., Kuo, Y., Freeman, J. L., & Goodwin, J. S. (2006) · Cancer · doi:10.1002/cncr.21999 · Cited by 43
Cited by
Exploring treatment options in cancer: tumor treatment strategies
Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201
Proton therapy – Present and future
Mohan, R., & Grosshans, D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.11.006 · Cited by 608
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
Kamada, T., Tsujii, H., Blakely, E. A., Debus, J., De Neve, W., Durante, M., Jäkel, O., Mayer, R., Orecchia, R., Pötter, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70412-7 · Cited by 562
Charged-particle therapy in cancer: clinical uses and future perspectives
Durante, M., Orecchia, R., & Loeffler, J. S. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.30 · Cited by 484
Strategies for optimizing the response of cancer and normal tissues to radiation
Moding, E. J., Kastan, M. B., & Kirsch, D. G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4003 · Cited by 461
Metadata
- Authors
- Goldin, G. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-04-18
- Volume
- 307
- Issue
- 15
- Pages
- 1611
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2134773558
- Cited by
- 445
- References
- 33
- FWCI
- 45.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.